论文部分内容阅读
目的:观察复方丹参联合抗痨药物治疗肺结核临床效果。方法:选取我院自2012年4月-2013年4月间收治的被确诊为肺结核的患者84例作为研究对象,随机将其分成两组,即对照组患者42例采用3HRPZ/4HR加保肝治疗,观察组患者在对照组基础上采用复方丹参治疗,对比两组患者的痰菌转阴情况和肺内病灶吸收情况。结果:观察组患者的肺内病灶吸收情况明显优于对照组,两组和数据对比差异具有统计学意义,P<0.05,痰菌转阴的状况两组对比差异不具有统计学意义,P>0.05。结论:传统抗痨药物联合复方丹参治疗肺结核病疗效确切,因此非常值得临床治疗上推广使用。
Objective: To observe the clinical effect of compound Danshen combined with anti-tuberculosis drugs in the treatment of pulmonary tuberculosis. Methods: Totally 84 patients diagnosed as pulmonary tuberculosis admitted to our hospital from April 2012 to April 2013 were randomly divided into two groups: control group (n = 42) received 3HRPZ / 4HR plus liver protection Treatment, observation group patients in the control group based on the use of compound Salvia treatment, the two groups of patients with sputum negative conversion and intrapulmonary lesions absorption. Results: The intra-lung lesion absorption in the observation group was significantly better than that in the control group, and the difference between the two groups was statistically significant (P <0.05). There was no significant difference between the two groups (P> 0.05. Conclusion: The traditional anti-tuberculosis drugs combined with Salvia miltiorrhiza in the treatment of pulmonary tuberculosis is effective, so it is worth to promote the use of clinical treatment.